Home > Boards > US Listed > Biotechs > MannKind Corp. (MNKD)

Too early to tell IMO. Not too late

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
downtrade Member Profile
 
Followed By 1
Posts 56
Boards Moderated 0
Alias Born 03/13/13
160x600 placeholder
MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference GlobeNewswire Inc. - 11/29/2019 9:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/21/2019 4:13:25 PM
MannKind Appoints Tony Hooper to Its Board of Directors GlobeNewswire Inc. - 11/21/2019 9:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/8/2019 4:03:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2019 8:01:23 AM
MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results GlobeNewswire Inc. - 11/6/2019 8:00:00 AM
MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics GlobeNewswire Inc. - 11/4/2019 9:00:00 AM
MannKind Corporation to Hold 2019 Third Quarter Financial Results Conference Call on November 6, 2019 GlobeNewswire Inc. - 10/30/2019 9:00:05 AM
MannKind Corporation to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire Inc. - 9/26/2019 9:00:00 AM
MannKind Presents Positive Afrezza® Clinical Data from Type 1 Diabetes Study at 55th Annual Meeting of the EASD GlobeNewswire Inc. - 9/19/2019 9:00:00 AM
MannKind Corporation to Present at H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire Inc. - 8/30/2019 9:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2019 4:08:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2019 4:05:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2019 4:02:50 PM
MannKind Corporation Reports 2019 Second Quarter Financial Results and Recent Business Highlights GlobeNewswire Inc. - 8/7/2019 4:01:00 PM
MannKind and One Drop Sign Collaboration Agreement to Integrate Bluetooth-Connected Inhaler with Dose Detection into the One ... GlobeNewswire Inc. - 8/5/2019 9:00:00 AM
MannKind Corporation to Hold 2019 Second Quarter Financial Results Conference Call on August 7, 2019 GlobeNewswire Inc. - 8/1/2019 5:02:20 PM
Afrezza® Safety and Pharmacokinetics Study in Pediatric Patients Opens Enrollment for Cohort 3 GlobeNewswire Inc. - 7/31/2019 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/18/2019 9:11:39 AM
MannKind Repays Maturing Debt Obligation; Buys Back Certain Warrants GlobeNewswire Inc. - 7/18/2019 8:52:49 AM
MannKind Partners with GoodRx to Help Raise Awareness on Reducing Out of Pocket Insulin Cost for Patients GlobeNewswire Inc. - 7/15/2019 9:00:00 AM
MannKind Expands Commercial Scale Manufacturing Capabilities for High-Potency Molecules GlobeNewswire Inc. - 7/11/2019 4:14:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2019 6:07:20 AM
MannKind to Present at the JMP Securities Life Sciences Conference GlobeNewswire Inc. - 6/12/2019 9:00:00 AM
MannKind Presents Positive Afrezza® Clinical Data from Three Studies at ADA 79th Scientific Sessions GlobeNewswire Inc. - 6/9/2019 2:00:00 PM
downtrade   Wednesday, 02/12/14 10:14:41 AM
Re: bsdvs23 post# 2487
Post # of 31714 
Too early to tell IMO. Not too late to see a green closing today closing higher than 5,85/5,90.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist